GetTopicDetailResponse(id=cc0d550e0f9, topicName=抗CEACAM5, introduction=抗CEACAM5, content=null, image=null, comments=2, allHits=708, url=https://h5.medsci.cn/topic?id=55070, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=57205, tagList=[TagDto(tagId=57205, tagName=抗CEACAM5)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2037051, encodeId=2c07203e051d3, content=<a href='/topic/show?id=cc0d550e0f9' target=_blank style='color:#2F92EE;'>#抗CEACAM5#</a>, objectTitle=Clin Cancer Res：CEACAM5的調(diào)控及抗CEACAM5-SN38抗體-藥物結(jié)合物在神經(jīng)內(nèi)分泌前列腺癌中的治療效果 , objectType=article, longId=204057, objectId=4ed120405e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ed120405e9f, replyNumber=0, likeNumber=106, createdTime=2020-12-30, rootId=0, userName=wgx306, userId=4193478, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ed120405e9f, moduleTitle=Clin Cancer Res：CEACAM5的調(diào)控及抗CEACAM5-SN38抗體-藥物結(jié)合物在神經(jīng)內(nèi)分泌前列腺癌中的治療效果 , moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4ed120405e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037050, encodeId=a6e1203e0507b, content=<a href='/topic/show?id=cc0d550e0f9' target=_blank style='color:#2F92EE;'>#抗CEACAM5#</a>, objectTitle=JCO：抗CEACAM5單抗/SN-38加合物治療轉(zhuǎn)移性結(jié)直腸癌前景良好？, objectType=article, longId=110590, objectId=4e791105909a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e791105909a, replyNumber=0, likeNumber=92, createdTime=2017-11-27, rootId=0, userName=wgx306, userId=4193478, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e791105909a, moduleTitle=JCO：抗CEACAM5單抗/SN-38加合物治療轉(zhuǎn)移性結(jié)直腸癌前景良好？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4e791105909a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
